Back

Elevated PCSK9 levels may contribute to dyslipidemia early after cardiac trasplantation

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic heart failure – Treatment Heart Transplantation ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Vojtech Melenovsky

Institute for Clinical and Experimental Medicine (IKEM), Prague (Czechia)

7 More presentations in this session

Presentation thumbnail
Vertebral fractures and bone metabolism impairment after heart transplant: results from a prospective cohort study
Doctor L. Seguro (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Rejection diagnostics with digital droplet PCR measuring donor-derived cell-free DNA: A retrospective proof-of-concept study in heart-transplanted patients
Doctor J. Boehmer (Gothenburg, SE)
Abstract Slides
Presentation thumbnail
Quality of life in recipients after heart transplantation
Doctor M. Simonenko (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Effect of left ventricular assist device implantation on complement activation of the cardiac allograft in the early post-heart transplant course
Doctor A. Schneider (Copenhagen, DK)
Abstract
Presentation thumbnail
Plasmatic levels of several microRNAs are altered during acute cellular rejection in patients after heart transplantation
Doctor J. Novak (Brno, CZ)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic heart failure – Treatment

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018
You may be interested in
thumbnail
Congress Presentation
Dealing with Heart Failure (again) after Cardiac Transplant
thumbnail
Congress Presentation
Hemochromatosis-induced cardiomyopathy
thumbnail
Congress Presentation
The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources